The integrated effects of angiotensin II

American Journal of Cardiology

Volumn 79, Issue 5 A, 1997, Pages 9-11

  Cody, Robert J ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN RECEPTOR; BRADYKININ; DIPEPTIDYL CARBOXYPEPTIDASE; FIBRONECTIN; NITRIC OXIDE;

BLOOD VESSEL TONE; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; CORONARY ARTERY DISEASE; GROWTH REGULATION; HEART FAILURE; HORMONE ACTION; HUMAN; HUMAN CELL; HYPERTENSION; INFLAMMATION; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0030908308     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00123-9     Document Type: Conference Paper

References (22)

1. Cody RJ. The clinical potential of renin inhibitors and angiotensin antagonists. Drugs 1994;47:586-598.
2. Dzau VJ. Tissue renin-angiotensin system in myocardial hypertrophy and failure. Arch Intern Med 1993;153:937-942.
3. Cody RJ. Renin system inhibition: Beginning The Fourth Epoch. Circulation 1992;85:362-364.
4. Dzau VJ. Angiotensin-converting enzyme as a multimechanistic factor in CAD. J Myocard Ischemia 1995;7(suppl 1):6-14.
5. Cody RJ. ACE inhibitors: myocardial infarction and congestive heart failure. Am Fam Physician 1995;52:1801-1806.
6. Cody RJ. ACE inhibitors: mechanisms, pharmacokinetics, and clinical trials in heart failure. Cardiol Rev 1994;3:145-156.
7. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992;327:685-691.
8. Kleber FX, Niemöller L, Doering W. Impact of converting enzyme inhibition on progression of chronic heart failure: results of the Munich Mild Heart Failure Trial. Br Heart J 1992;67:289-296.
9. Laragh JH. The renin system and the impact of ACE inhibition for understanding, diagnosis, and treatment of hypertension. In: Sonnenblick EH, Laragh JH, Lesch M, eds. New Frontiers in Cardiovascular Therapy: Focus on Angiotensin Converting Enzyme Inhibition. Princeton, NJ: Excerpta Medica, 1989:83-116.
10. Weber MA, Neutel JM, Smith DHG. Circulatory and extracirculatory effects of angiotensin-converting enzyme inhibition. Am Heart J 1992;123:1414-1420.
11. Fabris B, Chen B, Pupic V, Perich R, Johnston CI. Inhibition of angiotensin-converting enzyme (ACE) in plasma and tissue. J Cardiovasc Pharmacol 1990;15(suppl 2):S6-S13.
12. Kang PM, Landau AJ, Eberhardt RT, Frishman WH. Angiotensin II receptor antagonists: a new approach to blockade of the renin-angiotensin system. Am Heart J 1994;127:1388-1401.
13. Ollivier J-P, Bouchet VA. Prospects for cardioreparation. Am J Cardiol 1992;70(suppl C):27C-36C.
14. Feener EP, Northrup JM, Aiello LP, King GL. Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells. J Clin Invest 1995;95:1353-1362.
15. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium: fibrosis and renin-angiotensin-aldosterone system. Circulation 1991;83:1849-1865.
16. Weber KT, Sun Y, Guarda E. Structural remodeling in hypertensive heart disease and the role of hormones. Hypertension 1994;23(pt 2):869-877.
17. van Leeuwen RTJ, Kol A, Andreotti F, Kluft C, Maseri A, Sperti G. Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells. Circulation 1994;90:362-368.
18. 1 receptors mediate a positive inotropic effect of angiotensin II in guinea pig atria. Eur J Pharmacol 1993;245:63-66.
19. Studer R, Reinecke H, Müller B, Holtz J, Just H, Drexler H. Increased angiotensin-I converting enzyme gene expression in the failing human heart Quantification by competitive RNA polymerase chain reaction. J Clin Invest 1994;94:301-310.
20. Peach MJ, Dostal DE. The angiotensin II receptor and the actions of angiotensin II. J Cardiovasc Pharmacol 1990;16(suppl 4):S25-S30.
21. Kai H, Griendling KK, Lasségue B, Ollerenshaw JD, Runge MS, Alexander RW. Agonist-induced phosphorylation of the vascular type 1 angiotensin II receptor. Hypertension 1994;24:523-527.
22. Konstam MA, Dracup K, Baker DW, Bottorff MB, Brooks NH, Dacey RA, Dunbar SB, Jackson AB, Jessup M, Johnson JC, Jones RH, Luchi RJ, Massie BM, Pitt B, Rose EA, Rubin LJ, Wright RF, Hadorn DC. Heart Failure: Evaluation and Care of Patients with Left-Ventricular Systolic Dysfunction. AHCPR Publication 94-0612. Rockville, MD: Agency for Health Care Policy and Research, Public Health Service, US Department of Health and Human Services. June 1994.